Mariner’s Applied Therapeutics APLT Stock Holding History

Mariner’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,328	Closed	-$10.6K	–	3441
2024 Q4	$10.6K	Buy	+12,328	New	+$77.3K	﹤0.01%	3364

Other funds holding APLT

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mariner's APLT Position: Q1 2025 in Review

Mariner sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 12,328 shares — an estimated $10.6K sold.

Mariner first reported a position in APLT in Q4 2024 and held it in 1 quarter. The position peaked at $10.6K in Q4 2024. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

Mariner reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
Mariner sold 12,328 Applied Therapeutics shares in Q1 2025, an estimated $10.6K.
Mariner first reported a position in Applied Therapeutics in Q4 2024 and held it in 1 quarter.
Mariner's Applied Therapeutics position peaked at $10.6K in Q4 2024.
89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Mariner's 13F filing for Q1 2025, filed 15 May 2025.